Clinical Trial: Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects

Brief Summary: In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy

Detailed Summary:
Sponsor: University of Zurich

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Zurich

Dates:
Date Received: August 27, 2008
Date Started: August 2008
Date Completion:
Last Updated: August 18, 2010
Last Verified: September 2008